AIIMS CRE, SNO-2024: Urine copper and ceruloplasmin tests are diagnostic for which condition?

AIIMS CRE, SNO-2024

Biochemistry & Nutrition

Easy

Appeared in: AIIMS CRE, SNO-2024

Explanation

Wilson disease is an autosomal recessive genetic disorder characterized by the abnormal accumulation of copper in the body.
The underlying defect in the ATP7B gene impairs the incorporation of copper into ceruloplasmin, the primary copper-carrying protein, leading to low serum ceruloplasmin levels.
The body attempts to compensate by excreting excess copper through the kidneys, resulting in significantly elevated copper levels in a 24-hour urine sample.
Therefore, a combination of low serum ceruloplasmin and high urinary copper is a classic diagnostic indicator for Wilson disease.

Option A: Alzheimer's disease is a progressive neurodegenerative disorder. Its diagnosis relies on clinical cognitive assessments, neuroimaging (MRI, PET scans), and analysis of cerebrospinal fluid for biomarkers like amyloid-beta and tau proteins, not on copper metabolism tests.
Option C: Cushing's syndrome is an endocrine disorder caused by prolonged exposure to high levels of the hormone cortisol. It is diagnosed using tests that measure cortisol levels, such as a 24-hour urine free cortisol test, late-night salivary cortisol test, or a dexamethasone suppression test.
Option D: Addison's disease is primary adrenal insufficiency, where the adrenal glands do not produce enough cortisol and aldosterone. Diagnosis is confirmed with an ACTH (adrenocorticotropic hormone) stimulation test, which shows a low cortisol response, along with measurement of serum electrolytes.

Visual 1: Diagram: Pathophysiology of Wilson disease, illustrating how a faulty ATP7B protein leads to impaired biliary copper excretion and subsequent accumulation in the liver, brain, and cornea.
Visual 2: Image: Kayser-Fleischer rings, showing the characteristic golden-brown copper deposits in the periphery of the cornea, a pathognomonic sign of Wilson disease.
Visual 3: Flowchart: Diagnostic algorithm for Wilson disease, starting with clinical suspicion and proceeding through ceruloplasmin levels, 24-hour urine copper, and liver biopsy.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Biochemical diagnosis of Wilson disease as background academic context rather than a clinical decision trigger.
Nurses are responsible for accurately collecting a 24-hour urine sample, which includes providing clear instructions to the patient and using a copper-free collection container to ensure test validity.
Patient education is a critical nursing role, explaining that Wilson disease requires lifelong treatment with copper-chelating agents (like penicillamine or trientine) or zinc to prevent life-threatening complications.
Nurses must monitor patients for the effectiveness of treatment and for potential side effects of medications, as well as assess for any progression of hepatic, neurologic, or psychiatric symptoms.

How to Approach the Question

First, identify the keywords in the question stem: 'urine copper' and 'ceruloplasmin tests'.
Recognize that these are specific biochemical markers related to the body's metabolism of the trace metal copper.
Systematically evaluate each option based on its underlying pathology.
Rule out Alzheimer's disease, which is a neurodegenerative disorder diagnosed with cognitive and imaging tests.
Rule out Cushing's syndrome and Addison's disease, which are endocrine disorders related to the hormone cortisol, not copper.
Identify Wilson disease as the correct answer, as it is the classic genetic disorder of copper transport, directly diagnosed by assessing copper and ceruloplasmin levels.

Concept Tested & Keywords

Qihio8WEUJS1qdGqJvp-9W

E6 Textbook of Biochemistry for medical Students 11th Edition DM Vasudevan Part 2 — Subpart A (pp 1-239 of 478) p. 239-248